Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Merit Medical Systems, Inc. (MMSI)
Last merit medical systems, inc. earnings: 4/23 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
merit.com/investors
Company Research
Source: GlobeNewswire
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (“ACPP”) rate of 65.9%. Authors conclude the results suggest WRAPSODY Endoprosthesis is a safe and effective treatment for arteriovenous access circuit stenosis. SOUTH JORDAN, Utah, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of the Merit WRAPSODY Endoprosthesis. The WRAPSODY Endoprosthesis is a self-expanding, cell-impermeable endoprosthesis designed
Show less
Read more
Impact Snapshot
Event Time:
MMSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MMSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MMSI alerts
High impacting Merit Medical Systems, Inc. news events
Weekly update
A roundup of the hottest topics
MMSI
News
- Merit Medical Systems, Inc. (NASDAQ: MMSI) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Smart Syringe Market Analysis Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Nipro, Terumo, Merit Medical Systems, Gerresheimer, BD & Co, Revolutions Medical [Yahoo! Finance]Yahoo! Finance
- Merit Medical Systems, Inc. (NASDAQ: MMSI) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $98.00 price target on the stock.MarketBeat
- Merit Medical Systems, Inc. (NASDAQ: MMSI) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
MMSI
Earnings
- 2/28/24 - Beat
MMSI
Sec Filings
- 4/2/24 - Form ARS/A
- 4/2/24 - Form ARS
- 4/2/24 - Form DEFA14A
- MMSI's page on the SEC website